1,3,2-diazaphosphorine 2-oxides. 3. Preparation and biological evaluation of some 1,3-bis(aralkyl)-2-halo-1,3,2-diazaphosphorine 2-oxides and related compounds.
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002625:Chemistry, Organic; D046508:Culture Techniques; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D008113:Liver Neoplasms; D008175:Lung Neoplasms / Q000188:drug therapy; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy; D055601:Organic Chemistry Phenomena; D010087:Oxides / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000188:drug therapy
D000970:Antineoplastic Agents; D010087:Oxides; D010710:Phosphates